$0.58 -0.22 (-27.50%)
2/10/2012 3:59 PM

NeurogesX, Inc. (NASDAQ:NGSX)

CAPS Rating: 1 out of 5

A biopharmaceutical company, which focused on developing and commercializing novel pain management therapies.

Featured Broker Partners


Advertisement